Recent Studies: Daily intake of aspirin has no protective effect

A growing number of studies, especially since last year, have shown the risks of aspirin, which is not often mentioned.

This medicine, found in many homes, can cause bleeding.

A new badysis published in the Journal of the American Medical Association (gamma) showed that the benefits of aspirin in terms of cardiovascular health in healthy people are outweighed by an increased risk of bleeding, in particular. particular of the brain and intestines.

"There is no reason for healthy people to take regular aspirin," said cardiologist Sean Xing of Kings College in London.

"Our data show that there is a real risk.

People should not take this medicine as absolutely harmless. "

But the risks are very low: cardiovascular diseases are very rare in people with no history and bleeding in the case of aspirin.

According to the badysis, among the 265 people treated with aspirin over five years, only one heart attack problem will be avoided. However, one in every 210 patients treated with aspirin will have a dangerous haemorrhage.

These figures are not at all important for the cardiologist.

But researchers say these figures are important in terms of the total population, especially in the United States, where a study conducted in 2015 showed that 47% of Americans are in good health and taking aspirin.

A personal dilemma

Aspirin causes sepsis that prevents clotting and thus reduces the risk of heart attack or stroke.

For people who have already experienced such problems, taking a small dose of aspirin a day is good because the chance of preventing a new stroke is greater than the risk of bleeding.

But the controversy concerns people who have no precedent with a low probability of injury or difficulty identifying the risk.

In the United States, the highly respected United States Prosecution Task Force recommends taking aspirin in people 50 years of age who have a 10% chance of having a heart attack or clot over the next 10 years.

In Europe, aspirin is only recommended for people who have already had a heart attack.

The results of three major clinical trials published in 2018 contrast with the US recommendations.

She concluded that this drug is not helpful but is harmful to people who are not at high risk for people with diabetes.

The risk of internal hemorrhage preoccupies the seventies.

The new global scan examined 13 clinical trials conducted between 1998 and 2018 and found extracts based on all trials involving 164,000 people.

Doctors said that aspirin should be a priority to reduce cardiovascular risk, including smoking cessation, exercise and better nutrition, then examine each patient's case to find out if Aspirin was helpful to him or not.

But the badysis revealed no connection to cancer, while several recent studies have shown that aspirin reduces cancer, especially colon cancer.